Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Profiling alterations of the metabolomic and transcriptomic characteristics and the therapeutic mechanism of Psoraleae Fructus in treating kidney-yang deficiency syndrome rats

ABSTRACT: Profiling alterations of the metabolomic and transcriptomic characteristics and the therapeutic mechanism of Psoraleae Fructus in treating kidney-yang deficiency syndrome rats

PROVIDER: PRJNA1048841 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27067949_1.fastq.gz	Fastqsanger.gz
	SRR27067949_2.fastq.gz	Fastqsanger.gz
	SRR27067950_1.fastq.gz	Fastqsanger.gz
	SRR27067950_2.fastq.gz	Fastqsanger.gz
	SRR27067951_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

Profiling alterations of the metabolomic and transcriptomic characteristics and the therapeutic mechanism of Psoraleae Fructus in treating kidney-yang deficiency syndrome rats

Project description:Kidney-yang deficiency syndrome (KYDS) is a metabolic disease caused by neuroendocrine disorders often accompanied by abnormal liver function. Psoraleae Fructus (BGZ) is widely used to treat KYDS in China, but it is unclear whether BGZ plays a therapeutic role in regulating liver function. Organ index, ALT, AST, and HE staining were used to evaluate the protective effect of BGZ on KYDS in rats, and transcriptomics and metabolomics were employed to screen for potential biomarkers. The results showed that BGZ treatment significantly decreased the levels of ALT and AST, and ameliorated liver pathological damage in KYDS rats. 92 differentially expressed genes (DEGs) and 20 metabolites were significantly disturbed by BGZ in KYDS rats. Integrated analysis of metabolites and DEGs revealed that neuroactive ligand-receptor interaction, cAMP pathway, calcium signaling pathway, and cytokine-cytokine receptor interaction may be the main mechanism of BGZ treatment, and the key targets of the cAMP pathway were confirmed by ELISA and RT-qPCR. In conclusion, the cAMP pathway may be the partial mechanism by which BGZ exerts protective effects on KYDS, and the study results also lay the foundation for more in-depth mechanistic studies and drug-targeted therapy of KYDS in the future.

2023-12-31 | GSE249348 | GEO

Proteomic analysis of Fuzi and its processed products in treating Yang Deficiency Rats

Project description:The model rats of Yang deficiency syndrome were established by gavage of Huanglian and Dahuang and exhaustive swimming. The rats were treated with Fuzi, Yinfupian and Yangfupian. The liver tissue proteins were extracted and analyzed by TMT proteomics.

2021-05-27 | PXD026321 |

Setaria viridis strain:Yang 8054_China | cultivar:Yang 8054_China

Project description:Setaria viridis strain:Yang 8054_China | cultivar:Yang 8054_China Genome sequencing

| PRJNA333698 | ENA

Phoebe bournei (Hemsl.) Yang

Project description:Phoebe bournei (Hemsl.) Yang Raw sequence reads

| PRJNA889452 | ENA

Phoebe bournei (Hemsl.) Yang

Project description:Phoebe bournei (Hemsl.) Yang Raw sequence reads

| PRJNA889223 | ENA

Transcriptomic and Metabolomic Analyses Reveal Distinctive Metabolic Characteristics of Superficial and Deep Subcutaneous Adipose Tissues

Project description:Transcriptomic and Metabolomic Analyses Reveal Distinctive Metabolic Characteristics of Superficial and Deep Subcutaneous Adipose Tissues

| PRJNA895419 | ENA

Metabolomic heterogeneity of severe pulmonary arterial hypertension

Project description:Although multiple gene and protein expression have been extensively profiled in human pulmonary arterial hypertension (PAH), the mechanism for the development and progression of pulmonary hypertension remains elusive. Analysis of the global metabolomic heterogeneity within the pulmonary vascular system leads to a better understanding of disease progression. Using a combination of high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted glycolysis, increased TCA cycle, and fatty acid metabolites with altered oxidation pathways in the severe human PAH lung. The results suggest that PAH has specific metabolic pathways contributing to increased ATP synthesis for the vascular remodeling process in severe pulmonary hypertension. These identified metabolites may serve as potential biomarkers for the diagnosis of severe PAH. By profiling metabolomic alterations of the PAH lung, we reveal new pathogenic mechanisms of PAH in its later stage, which may differ from the earlier stage of PAH, opening an avenue of exploration for therapeutics that target metabolic pathway alterations in the progression of PAH. Global profiles were determined in human lung tissue and compared across 11 normal and 12 severe pulmonary arterial hypertension patients. Using a combination of microarray and high-throughput liquid-and-gas-chromatography-based mass spectrometry, we showed unbiased metabolomic profiles of disrupted glycolysis, increased TCA cycle, and fatty acid metabolites with altered oxidation pathways in the severe human PAH lung.

2014-11-14 | E-GEOD-53408 | biostudies-arrayexpress